Pasar al contenido principal

APROXIMACION ESTRUCTURAL PARA COMPRENDER ENZIMAS CLAVE EN RUTAS METABOLICAS, ERRORES CONGENITOS DEL METABOLISMO, Y PARA EL DISEÑO DE TERAPIAS DIRIGIDAS

PID2021-128468NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2

  • Steinberg-Shemer, Orna
  • Yacobovich, Joanne
  • Noy-Lotan, Sharon
  • Dgany, Orly
  • Krasnov, Tanya
  • Barg, Assaf
  • Landau, Yuval E.
  • Kneller, Katya
  • Somech, Raz
  • Gilad, Oded
  • Simon, Dafna Brik
  • Orenstein, Naama
  • Izraeli, Shai
  • Caño-Ochoa, Francisco del
  • Tamary, Hannah
  • Ramón-Maiques, Santiago
5 páginas, 2 figuras, Biallelic pathogenic variants in CAD, that encode the multienzymatic protein required for de-novo pyrimidine biosynthesis, cause early infantile epileptic encephalopathy-50. This rare disease, characterized by developmental delay, intractable seizures and anaemia, is amenable to treatment with uridine. We present a patient with macrocytic anaemia, elevated haemoglobin-A2 levels, anisocytosis, poikilocytosis and target cells in the blood smear, and mild developmental delay. A next-generation sequencing panel revealed biallelic variants in CAD. Functional studies did not support complete abrogation of protein function; however, the patient responded to uridine supplement. We conclude that biallelic hypomorphic CAD variants may cause a primarily haematological phenotype., This work was supported by grant PID2021-128468NB-I00 financed by Ministerio de Ciencia e Innovación / Agencial Estatal de Investigación (MCIN/AEI) (https://www.aei.gob. es/) and by grant CIVP20A6610 from Fundación Ramón Areces Ciencias de la Vida (XX National Call) (https://www. fundacionareces.es) to SR-M. FdC-O is a postdoctoral fellow of the Generalitat Valenciana (Valencian Local Government) (https://www.gva.es/) (APOSTD 2021)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Significance of utilizing in silico structural analysis and phenotypic data to characterize phenylalanine hydroxylase variants: A PAH landscape

  • Himmelreich, Nastassja
  • Ramón-Maiques, Santiago
  • Navarrete, Rosa
  • Castejón-Fernández, Natalia
  • Garbade, Sven F.
  • Martínez, Aurora
  • Desviat, Lourdes R.
  • Pérez, Belén
  • Blau, Nenad
11 páginas, 5 figuras, 1 tabla., Phenylketonuria (PKU) is a genetic disorder caused by variations in the phenylalanine hydroxylase (PAH) gene. Among the 3369 reported PAH variants, 33.7% are missense alterations. Unfortunately, 30% of these missense variants are classified as variants of unknown significance (VUS), posing challenges for genetic risk assessment. In our study, we focused on analyzing 836 missense PAH variants following the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines specified by ClinGen PAH Variant Curation Expert Panel (VCEP) criteria. We utilized and compared variant annotator tools like Franklin and Varsome, conducted 3D structural analysis of PAH, and examined active and regulatory site hotspots. In addition, we assessed potential splicing effect of apparent missense variants. By evaluating phenotype data from 22962 PKU patients, our aim was to reassess the pathogenicity of missense variants. Our comprehensive approach successfully reclassified 309 VUSs out of 836 missense variants as likely pathogenic or pathogenic (37%), upgraded 370 likely pathogenic variants to pathogenic, and reclassified one previously considered likely benign variant as likely pathogenic. Phenotypic information was available for 636 missense variants, with 441 undergoing 3D structural analysis and active site hotspot identification for 180 variants. After our analysis, only 6% of missense variants were classified as VUSs, and three of them (c.23A>C/p.Asn8Thr, c.59_60delinsCC/p.Gln20Pro, and c.278A >T/p.Asn93Ile) may be influenced by abnormal splicing. Moreover, a pathogenic variant (c.168G>T/p.Glu56Asp) was identified to have a risk exceeding 98% for modifications of the consensus splice site, with high scores indicating a donor loss of 0.94. The integration of ACMG/AMP guidelines with in silico structural analysis and phenotypic data significantly reduced the number of missense VUSs, providing a strong basis for genetic counseling and emphasizing the importance of metabolic phenotype information in variant curation. This study also sheds light on the current landscape of PAH variants., This work was supported in part by the Nenad Blau Endowment Fund of the MCF, Marin County, CA, USA, by grant PID2021–128468NB-I00 f inanced by MCIN/AEI/10.13039/501100011033 and by a grant from Fundaci´ on Ram´ on Areces Ciencias de la Vida (XX National Call) to Santiago Ram´ on-Maiques, by the Deutsche Forschungsgemeinschaft FOR2509 and TH1461/7–2 to Nastassja Himmelreich, by the Instituto de Salud Carlos (ISCIII), European Regional Development Fund [PI22/ 00699] to Bel´ en Per´ ez, and La Fundaci´ o la Marat´ o de TV3 (Project 202012-31-32-33) and the Neuro-SysMed Center (The Research Council of Norway, Project No. 288164) to Aurora Martinez., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disruption of CAD Oligomerization by Pathogenic Variants

  • Caño-Ochoa, Francisco del
  • Ramadane-Morchadi, Lobna
  • Eixerés, Lluís
  • Moreno-Morcillo, Maria
  • Fernández-Leiro, Rafael
  • Ramón-Maiques, Santiago
20 páginas, 9 figuras, 2 tablas, CAD, the multi-enzymatic protein essential for initiating the de novo biosynthesis of pyrimidine nucleotides, forms large hexamers whose structure and function are not fully understood. Defects in CAD cause a severe neurometabolic disorder that is challenging to diagnose. We developed a cellular functional assay to identify defective CAD variants, and in this study, we characterized five pathogenic missense mutations in CAD's dihydroorotase (DHO) and aspartate transcarbamoylase (ATC) domains. All mutations impaired enzymatic activities, with two notably disrupting the formation of DHO dimers and ATC trimers. Combining crystal structures and AlphaFold predictions, we modeled the hexameric CAD complex, highlighting the central role of the DHO and ATC domains in its assembly. Our findings provide insight into CAD's stability, function, and organization, revealing that correct oligomerization of CAD into a supramolecular complex is required for its function in nucleotide synthesis and that mutations affecting this assembly are potentially pathogenic., This work was supported by grants PID2021-128468NB-I00 and PID2020-120258GB-I00 financed by MCIN/AE I/10.13039/501100011033 to SR-M and RF-L, respectively, and from Fundacio´n Ramo´n Areces Ciencias de la Vida (XX National Call) to SR-M, and Ramon y Cajal fellowship RYC-2017-23128 to RF-L. LRM was partially supported by the FIBHCSC intramural young researcher mobility fellowship program 2023, FIB-HCSC, Madrid, Spain. X-ray diffraction experiments at synchrotrons were done through the participation of SR-M in the BAG proposals 2023077633 at ALBA, and MX-2452 at the European Synchrotron Radiation Facility (ESRF) with DOI 10.15151/ESRF-ES-1117952942., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot-Marie-Tooth Disease

  • Estévez-Arias, Berta
  • Sarv, Siiri
  • Bonello-Palot, Nathalie
  • Carrera-Garcia, Laura
  • Ortez, Carlos
  • Expósito-Escudero, Jesica
  • Yubero, Delia
  • Muchart, Jordi
  • Delmont, Emilien
  • Oiglane-Shlik, Eve
  • Meren, Teele
  • Puusepp, Sanna
  • Murumets, Ülle
  • Salomons, Gajja S.
  • Udd, Bjarne
  • Väli, Liis
  • Cantarero, Lara
  • Bönnemann, Carsten G.
  • Nascimento, Andrés
  • Ramón-Maiques, Santiago
  • Õunap, Katrin
  • Hoenicka, Janet
  • Natera-de Benito, Daniel
  • Palau, Francesc
17 páginas, 5 figuras, 2 tablas, Objective: Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of genetic neuropathies, with >90 genes identified. Several aminoacyl-tRNA synthetases have been linked to CMT. DARS2, encoding the mitochondrial aspartyl-tRNA synthetase, has been typically associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation. This study aimed to investigate the association between biallelic DARS2 variants and axonal CMT. Methods: We investigated 5 individuals from 3 unrelated families with axonal CMT and biallelic DARS2 variants. Functional studies in fibroblasts assessed their effects on DARS2 expression, localization, and mitochondrial function. Enzymatic activity was evaluated in HEK293 cells. Results: The 5 individuals, including 4 adults, presented with childhood-onset progressive axonal CMT. None had leukoencephalopathy, but one showed central nervous system involvement, with intellectual disability and epilepsy. Genetic analysis identified compound heterozygous DARS2 variants: family A, p.Ser238Phe and p.Arg336Cys; family B, p.Ser238Phe and p.Ile25Thrfs*38; family C, c.492+2T>C and p.Pro503Leu. Functional studies revealed reduced DARS2 protein levels, mitochondrial network abnormalities, and impaired mitochondrial function. p.Ser238Phe behaves as a hypomorphic allele, whereas p.Pro503Leu reduced DARS2 enzymatic activity by 75%. Interpretation: Our findings expand the DARS2-related disease spectrum, establishing a novel association with axonal CMT. Hypomorphic variants, such as p.Ser238Phe, when paired with more deleterious variants, result in isolated axonal CMT, whereas more severe combinations-although not as deleterious as those seen in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation-result in axonal CMT with central nervous system involvement, albeit without leukoencephalopathy. These observations raise the possibility that DARS2-associated diseases form a continuum rather than representing strictly distinct central or peripheral nervous system disorders., B.E.A. was supported by the predoctoral program “Joan Oró” of the Secretary of Universities and Research of the Department of Research and Universities of the Government of Catalonia with code 2025 FI-2 00075, cofinanced by the European Union. D.NdB. was supported by the Miguel Servet program from Instituto de Salud Carlos III, Spain (CP22/00141). The FP research group is funded by the Spanish Research Agency (AEI) grant PID2020-114655RB-I00, the European Union’s Horizon Europe research and innovation program under grant agreement No 101136262, and the AGAUR, Generalitat de Catalunya, grant 2021-SGR-01610. S.S. and K.Õ. are supported by the Estonian Research Council grants PRG471 and PRG2040, and funding IDOLS-G from Estonian Social Ministry as a part of the European Joint Program on Rare Diseases (EJP-RD). S.R-M. is supported by grant PID2021-128468NB-I00 financed by MCIN/AEI/10.13039/501100011033 and by grant from Funcaci on Ram on Areces Ciencias de la Vida, CC National call. B.E.A., C.O., C.J., J.E.E., L.C.G., A.N., L.V., and D.NdB. are members of the European Reference Network for Neuromuscular Diseases ERN-NMD – Project ID No. 870177. F.P. and K.Õ. are members of the ERN-ITHACA on Rare Malformations Syndromes, Intellectual and Other Neurodevelopmental Disorders, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From genotype to outcome: Zygosity-specific insights in 63 cases of CLPB-related mitochondrial disease

  • Heath, Oliver
  • Caño-Ochoa, Francisco del
  • Baris, Safa
  • Carrozzo, Rosalba
  • Coman, David
  • Distelmaier, Felix
  • Ellaway, Carolyn
  • Feichtinger, Rene G.
  • Finocchi, Andrea
  • Guerrero-Castillo, Sergio
  • Halligan, Rebecca
  • Hannibal, Iris
  • Kritzer, Amy
  • Lichter-Konecki, Uta
  • Merkevicius, Kajus
  • Panis, Bianca
  • Pitceathly, Robert D. S.
  • Pizzamiglio, Chiara
  • Iwanicka-Pronicka, Katarzyna
  • Rahman, Shamima
  • Seltzer, Laurie
  • Siepermann, Meinolf
  • Tal, Galit
  • Wevers, Ron A.
  • Zietkiewicz, Szymon
  • Ramón-Maiques, Santiago
  • Mayr, Johannes A.
  • Wortmann, Saskia B.
15 páginas, 5 figuras, 2 tablas, Background: CLPB-related mitochondrial disease causes congenital neutropenia, developmental delay/intellectual disability, progressive brain atrophy, movement disorders, cataracts, and 3-methylglutaconic aciduria. Both monoallelic and biallelic forms exist. This retrospective cohort study compared clinical outcomes and genotype-structure-phenotype correlations across zygosity groups. Methods: Sixty-three individuals (41 biallelic, 22 monoallelic; 6 unpublished) with disease-causing CLPB variants were identified via literature review and a multicenter survey. In silico modeling assessed structural impact. A modified CLPB Disease Burden Index (DBI) quantified severity. Results: Median age at last follow-up was 4.0 years (IQR: 0.25-12.6) in biallelic and 12.0 years (IQR: 5.3-21.0) in monoallelic cases. Death occurred in 66% of biallelic and 23% of monoallelic individuals, with earlier median age at death in biallelic cases (6 months vs 2.4 years). Biallelic cases had significantly higher DBI scores and poorer survival (4-year survival: 50% vs 82%). Stop/stop genotypes were associated with greater disease burden than missense combinations. Structural predictions-particularly variants causing nonsense-mediated decay or ankyrin domain disruption-were stronger survival predictors than zygosity or age of onset. Early-onset disease (<12 months) correlated with more severe progression. Later onset often resulted in milder phenotypes. Hematologic and neurologic features overlapped across zygosity; cataracts and dystonia were more common in biallelic cases. Milestone attainment was poor, with <50% walking or speaking, and only 10-20% doing so on time. Four monoallelic patients received hematopoietic stem cell transplants with mixed outcomes. Granulocyte colony-stimulating factor was associated with improved survival. Conclusions: This is the largest cohort study to date comparing biallelic and monoallelic CLPB deficiency. Structural variant impact-particularly ankyrin domain disruption-emerged as a key prognostic factor., This research was funded in whole or in part by Austrian Science Fund (FWF) [I-4704-B], and by grant PID2021-128468NB-I00 financed by MCIN/AEI/10.13039/501100011033 to SR-M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case report

  • Al-Younis, Inas
  • Basque, Laurence
  • Crapoulet, Nicolas
  • Dyack, Sarah
  • Caño-Ochoa, Francisco del
  • Ramón-Maiques, Santiago
  • MacKay, Sara B.
  • Rzasa, Jessica
  • Sadikovic, Bekim
  • McConkey, Haley
  • Ben Amor, Mouna
9 páginas, 3 figuras., Background: Neurodevelopmental disorders (NDDs) are genetically heterogeneous, and standard genomic testing frequently yields variants of uncertain significance (VUS) or misses cryptic structural variants. Episignature analysis, which detects disorder specific genome-wide DNA methylation patterns, has emerged as a functional tool to resolve diagnostic uncertainty. Case presentation: We report a 7-year-old female with global developmental delay, autism spectrum disorder, epilepsy, microcephaly, and a distinctive facial gestalt. Initial trio whole-exome sequencing identified inconclusive VUSs in CAD and POLR1A. A therapeutic trial of uridine for the CAD-related variants provided only transient benefit. Genome-wide DNA methylation analysis via EpiSign revealed a positive result for the episignature for Intellectual Developmental Disorder, Autosomal Dominant 7 (MRD7), associated with DYRK1A haploinsufficiency. Guided by this result, trio whole-genome sequencing identified a de novo heterozygous deletion involving exon 5 of DYRK1A. The exact breakpoints were chr21:38,852,074-38,856,009 (GRCh37/hg19) and chr21:39,044,532-39,048,467 (GRCh38/hg38). This variant was reclassified from VUS to likely pathogenic based on concordant episignatures findings, clinical phenotype, and de novo occurrence. Conclusion: This case highlights the utility of episignature analysis to help diagnose NDD patients, guide further molecular diagnostic testing, and as a functional assay to aid variant reclassification. Integration of epigenomic profiling with standard of care testing can shorten the diagnostic odyssey, prevent unnecessary interventions, and directly inform clinical management in patients with unresolved NDDs. Keywords: DNA methylation; DYRK1A; case report; diagnostic odyssey; episignatures; neurodevelopmental disorder; variant of uncertain significance (VUS); whole-genome sequencing., This work was funded by the government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-188) and Centre de Formation Medical du NB. SR-M was funded by grant PID 2021-128468NB-I00 financed by MCIN/AEI/10.13039/501100011033., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares - líneas inmortalizadas humanas, in vitro - Sistemas de cultivo - Cultivos 2D - Cultivo 2D sin fluídica